WinstonWınston
Back
4DMedical Limited logo

4DMedical Limited

FDMDF
25
Medical - Devices · Healthcare
Price
$2.95
+0.00 (+0.00%)
Market Cap
$1.77B
Exchange
Other OTC
Winston Score
25
Winston is worried
Below-average fundamentals — multiple weak pillars.
Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.
Data as of Aug 23, 2026 · filings through Dec 31, 2025
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Good
Valuation
Data not available

Share count rising — dilution

+62.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 261.4M (2021) → 424.3M (2025)

Winston Score History

The full picture

4DMedical is an Australian medical technology company that makes software for measuring how well lungs work. Its main product, called XV Technology, uses a standard CT scanner to create detailed images showing how air moves through the lungs — something traditional lung tests cannot do as clearly. The company sells its technology to hospitals, radiology clinics, and military health programs, primarily in the United States and Australia.

4DMedical earns revenue by charging for each scan analyzed using its software, a model sometimes called "per-scan" or fee-for-service pricing. The company has a contract with the U.S. Department of Veterans Affairs, which gives it a meaningful foothold in a large, government-funded customer base. However, the deeply negative margins shown in recent financial periods make clear that 4DMedical is spending far more than it earns right now, and the key risk is whether it can grow scan volumes fast enough to reach profitability before needing to raise additional capital.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-1.5% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-900.0% YoY

YoY Growth Rate

Earnings declining

R&D Spend

A$3M/ year

Rising (+261% vs prior year)

42.8% of revenue

2.4x the sector average (18%)

Investing heavily in future products and technology

Insider Activity

26.2%ownership

Insiders own a meaningful stake in the company

Cash Runway

~13 months

A$57M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Adequate runway but may need to raise capital within 2 years

Heavy R&D investment

4DMedical Limited is putting 43% of revenue into R&D and that number is rising. That's 2.4x the sector average.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
92.1%
Premium pricing power — 92.1% gross margin
Profit after running costs
Operating Margin
-499.2%
Losing money on operations — -499.2%
Return on the money invested
ROCE
-45.5%
Weak — -45.5% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+91.9%
Fast-growing sales (+91.9% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-590.4%
Burning cash (-590.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.00
Conservative — low debt load (0.00)
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial